174 related articles for article (PubMed ID: 12537672)
21. Complete ablation of small squamous cell carcinoma xenografts with 186Re-labeled monoclonal antibody E48.
Gerretsen M; Visser GW; Brakenhoff RH; van Walsum M; Snow GB; van Dongen GA
Cell Biophys; 1994; 24-25():135-42. PubMed ID: 7736517
[TBL] [Abstract][Full Text] [Related]
22. 186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice.
Beaumier PL; Venkatesan P; Vanderheyden JL; Burgua WD; Kunz LL; Fritzberg AR; Abrams PG; Morgan AC
Cancer Res; 1991 Jan; 51(2):676-81. PubMed ID: 1845957
[TBL] [Abstract][Full Text] [Related]
23. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.
Behr TM; Memtsoudis S; Vougioukas V; Liersch T; Gratz S; Schmidt F; Lorf T; Post S; Wörmann B; Hiddemann W; Ringe B; Becker W
Anticancer Res; 1999; 19(4A):2427-32. PubMed ID: 10470170
[TBL] [Abstract][Full Text] [Related]
24. Anti-angiogenic therapy and radioimmunotherapy in colon cancer xenografts.
Kinuya S; Kawashima A; Yokoyama K; Kudo M; Kasahara Y; Watanabe N; Shuke N; Bunko H; Michigishi T; Tonami N
Eur J Nucl Med; 2001 Sep; 28(9):1306-12. PubMed ID: 11585288
[TBL] [Abstract][Full Text] [Related]
25. Biodistribution study of 188Re-labeled trisuccin-HuCC49 and trisuccin-HuCC49deltaCh2 conjugates in athymic nude mice bearing intraperitoneal colon cancer xenografts.
Safavy A; Khazaeli MB; Safavy K; Mayo MS; Buchsbaum DJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):2994s-3000s. PubMed ID: 10541333
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunotherapy of colorectal cancer liver metastases: combination with radiotherapy.
Buchegger F; Roth A; Allal A; Dupertuis YM; Slosman DO; Delaloye AB; Mach JP
Ann N Y Acad Sci; 2000 Jun; 910():263-9; discussion 269-70. PubMed ID: 10911919
[TBL] [Abstract][Full Text] [Related]
27. Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials.
Breitz HB; Weiden PL; Vanderheyden JL; Appelbaum JW; Bjorn MJ; Fer MF; Wolf SB; Ratliff BA; Seiler CA; Foisie DC
J Nucl Med; 1992 Jun; 33(6):1099-109. PubMed ID: 1597723
[TBL] [Abstract][Full Text] [Related]
28. Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer.
Phaeton R; Jiang Z; Revskaya E; Fisher DR; Goldberg GL; Dadachova E
Cancer Med; 2016 Jan; 5(1):9-16. PubMed ID: 26625938
[TBL] [Abstract][Full Text] [Related]
29. Improved response of colon cancer xenografts to radioimmunotherapy with pentoxifylline treatment.
Kinuya S; Yokoyama K; Konishi S; Li XF; Watanabe N; Shuke N; Takayama T; Bunko H; Michigishi T; Tonami N
Eur J Nucl Med; 2001 Jun; 28(6):750-5. PubMed ID: 11440036
[TBL] [Abstract][Full Text] [Related]
30. Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.
Gestin JF; Loussouarn A; Bardiès M; Gautherot E; Gruaz-Guyon A; Saï-Maurel C; Barbet J; Curtet C; Chatal JF; Faivre-Chauvet A
J Nucl Med; 2001 Jan; 42(1):146-53. PubMed ID: 11197965
[TBL] [Abstract][Full Text] [Related]
31. Improved tumor targeting of rhenium-186-labeled anti-human high-m.w. melanoma-associated antigen monoclonal antibody 763.74 following purification with anti-idiotypic monoclonal antibody MK2-23.
Hamby CV; Chinol M; Palestro CJ; Manzo C; Ferrone S
Int J Cancer; 1998 Nov; 78(4):486-90. PubMed ID: 9797138
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant 131I-anti-CEA-antibody radioimmunotherapy inhibits the development of experimental colonic carcinoma liver metastases.
Mahteme H; Lövqvist A; Graf W; Lundqvist H; Carlsson J; Sundin A
Anticancer Res; 1998; 18(2A):843-8. PubMed ID: 9615730
[TBL] [Abstract][Full Text] [Related]
33. Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin.
de Jong GM; Hendriks T; Eek A; Oyen WJ; Heskamp S; Bleichrodt RP; Boerman OC
Ann Surg Oncol; 2009 Jul; 16(7):2065-73. PubMed ID: 19430843
[TBL] [Abstract][Full Text] [Related]
34. Biodistribution, pharmacokinetic, and imaging studies with 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice.
Goldrosen MH; Biddle WC; Pancook J; Bakshi S; Vanderheyden JL; Fritzberg AR; Morgan AC; Foon KA
Cancer Res; 1990 Dec; 50(24):7973-8. PubMed ID: 2253238
[TBL] [Abstract][Full Text] [Related]
35. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen.
Lu QJ; Bian GX; Chen YY; Zhang M; Guo SM; Wen LQ
Acta Pharmacol Sin; 2005 Oct; 26(10):1259-64. PubMed ID: 16174444
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic intervention with angiotensin II and kininase inhibitor enhanced efficacy of radioimmunotherapy in human colon cancer xenografts.
Kinuya S; Yokoyama K; Kawashima A; Hiramatsu T; Konishi S; Shuke N; Watanabe N; Takayama T; Michigishi T; Tonami N
J Nucl Med; 2000 Jul; 41(7):1244-9. PubMed ID: 10914917
[TBL] [Abstract][Full Text] [Related]
38. Phase I therapy study with (186)Re-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with head and neck squamous cell carcinoma.
Börjesson PK; Postema EJ; Roos JC; Colnot DR; Marres HA; van Schie MH; Stehle G; de Bree R; Snow GB; Oyen WJ; van Dongen GA
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3961S-72S. PubMed ID: 14506195
[TBL] [Abstract][Full Text] [Related]
39. Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.
van Gog FB; Brakenhoff RH; Stigter-van Walsum M; Snow GB; van Dongen GA
Int J Cancer; 1998 Jul; 77(1):13-8. PubMed ID: 9639387
[TBL] [Abstract][Full Text] [Related]
40. Methylxanthine sensitization of human colon cancer cells to 186Re-labeled monoclonal antibody.
Kinuya S; Yokoyama K; Kudo M; Kasahara Y; Kobayashi K; Motoishi S; Onoma K; Bunko H; Michigishi T; Tonami N
J Nucl Med; 2001 Apr; 42(4):596-600. PubMed ID: 11337548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]